AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Traws Pharma, Inc. Director's Dealing 2013

Nov 20, 2013

35199_dirs_2013-11-20_0887ae6f-82ae-460e-93f7-51a2ac8d089e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-18

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-18	Common Stock	P	5000	$11.87	Acquired	4312500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	84530	Indirect

Footnotes

F1: These shares are held in trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.